Suchergebnisse - "Wang, Yuxia"

PubPharm (6)

1

HJM-561, a Potent, Selective, and Orally Bioavailable EGFR PROTAC that Overcomes Osimertinib-Resistant EGFR Triple Mutations

enthalten in: Molecular cancer therapeutics | 2022

von Du, Y. | Chen, Y. | Wang, Y. | +7

2

The efficacy of anlotinib instead of glucocorticoids for edema induced by brain metastases in NSCLC patients with anti-PD1/PDL-1 immunotherapy

enthalten in: Neuro-oncology | 2021

von Zhuang, H. | Wang, Y. | Cheng, C. | +1

3

Stereotactic radiosurgery combined with anlotinib for limited brain metastases with perilesional edema in non-small cell lung cancer : Rvision-001 study protocol

enthalten in: Thoracic cancer | 2020

von Wang, Y. | Wang, X. | Guan, Y. | +3

4

Discovery of the Polyamine Conjugate with Benzo[ cd]indol-2(1 H)-one as a Lysosome-Targeted Antimetastatic Agent

enthalten in: Journal of medicinal chemistry | 2018

von Li, J. | Tian, R. | Ge, C. | +10

5

Prolonged blockade of VEGF receptors does not damage retinal photoreceptors or ganglion cells

enthalten in: Journal of cellular physiology | 2010

von Miki, A. | Miki, K. | Ueno, S. | +7

6

Impaired formation of the inner retina in an AChE knockout mouse results in degeneration of all photoreceptors

enthalten in: The European journal of neuroscience | 2004

von Bytyqi, A. | Lockridge, O. | Duysen, E. | +3

1
[1]